Supported by Grants R01EY027833, DP3 DK104397, R01 EY024544, R01 EY023285, P30 EY010572, T32 EY023211-05 from the National Institutes of Health (Bethesda, MD), and an unrestricted departmental funding grant and William & Mary Greve Special Scholar Award from Research to Prevent Blindness (New York, NY), and the Antonio Champalimaud Vision Award.
Disclosure: A. Camino, Optovue, Inc. (P); M. Zhang, employed by Optovue, Inc. during the preparation of this manuscript (E); L. Liu, None; J. Wang, None; Y. Jia, has a significant financial interest in Optovue, Inc. (F, P); D. Huang, has a significant financial interest in Optovue, Inc. (F, I, P, R)